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Abstract Trigonella foenum graecum leaves are widely
used as a vegetable throughout India and have a long history
of medicinal use in Ayurveda and Chinese medicine. Even
though the leaves of this plant are used in diabetes mellitus,
there have been no in vivo studies to prove its efficacy. The
aim of this study was to know the efficacy of ethanol extract of
T. foenum graecum leaves on blood glucose levels, antioxi-
dant enzymes, islets cells of pancreas, creatinine and urea
levels in normal and streptozotocin induced diabetic rats.
Diabetes was induced by streptozotocin (45 mg/kg b.w. in
0.9 % cold saline). Two doses (250 and 500 mg/kg b.w.) of the
extracts were administered in the study. The activity was
compared with the reference standard glibenclamide
(0.5 mg/kg b.w.) for various biochemical and histopathologi-
cal parameters. The data was analysed by one way ANOVA
followed by Turkey’s post hoc test. The activity of the extract
in reducing blood glucose, creatinine and urea levels, in
enhancing antioxidant enzyme activity and restoring and
regenerating islet cells of pancreas was comparable to gliben-
clamide. The result suggests that ethanol leaf extract of T.
foenum graecum possesses significant antidiabetic property.
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Introduction
Diabetes Mellitus (DM) is a leading metabolic disorder
worldwide, caused by a deficiency in the production of
insulin in the beta cells of pancreas, or by the insulin
resistance. Such a deficiency results in the increased
concentration of glucose in the blood which results in
secondary complications affecting eyes, kidneys, nerves
and arteries. Experimental evidences suggest the in-
volvement of free radicals in the pathogenesis of diabetes [1]
and more importantly in the development of diabetic
complications [2].
Trigonella foenum graecum Linn. commonly known as
Fenugreek belongs to the family Fabaceae, which is an
annual, herbaceous and aromatic plant. It is one of the oldest
medicinal plants, originating in India and Northern Africa.
The leaves and seeds, which mature in long pods, are used
to prepare extracts or powders for medicinal use. In India,
fenugreek seeds are commonly consumed as a condiment.
Fresh and dried fenugreek leaves and tender stems are
edible which are widely used as a vegetable. Fenugreek
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is reported to have anti-diabetic, anti-fertility, anticancer,
anti-microbial, anti-parasitic, lactation stimulant and
hypocholesterolemic effects [8].
In view of the promising anti-diabetic potential of
fenugreek seeds, we have investigated the efficacy and
safety of ethanol extract of its leaves on blood glucose
levels, its effect on kidney parameters, antioxidant enzyme
activity in liver and islet cells of pancreas in streptozotocin
induced diabetic rats.
Material and Methods
Plant material
Fresh and healthy leaves of T. foenum graecum were
obtained from local market. The sample specimen was
identified based on the taxonomical characteristics and
deposited in the herbarium of department of Applied
Botany. The leaves were washed thoroughly in distilled
water and the surface water was removed by air drying
under shade. The leaves were subsequently dried in a
hot air oven at 40° C for 48 h, powdered and used for
extraction.
Preparation of solvent extract
Fifty grams of the powdered material was extracted initially
with 300 ml of ethanol for 24 h at 23±2 ° C. The extract was
filtered with sterile Whatman filter paper into a clean conical
flask. Second extraction was carried out with same amount
of solvent for another 24 h at 23±2 ° C and filtered. The
extracts were later pooled and transferred into the sample
holder of the rotary flash evaporator for the evaporation of
the solvents. The evaporated extract so obtained was
preserved at 4 ° C in airtight bottle until further use
[9]. The suspension of the extract was prepared by
dissolving the weighed amount in freshly prepared
1 % gum arabic solution.
Animals
Adult healthy Albino rats of Wistar strain of either sex
weighing 120–160 g with no prior drug treatment were used
in the present study. Animals were maintained at 22±2 ° C
with 12 h light and dark cycle. The animals were fed on
standard pellet diet and had free access to diet and water
throughout the experiment. Animals that are described as
fasting were deprived of food for at least 16 h but were
allowed free access to drinking water. Animal study was
performed in Central Animal Facility, JSS Medical College,
Mysore, with due permission from Institutional Animal
Ethics Committee.
Experimental design
The animals were randomly divided into the seven groups
with six animals in each group. Group A served as saline
control, group B and C served as normal controls who were
administered 250 and 500 mg /kg body weight (b.w.) of leaf
extract respectively to know the toxic effects of the extracts
if any on kidney and liver, group D as the diabetic control,
group E as the standard drug (glibenclamide, 0.5 mg/kg
b.w.) control and group F and G were diabetics treated with
250 and 500 mg /kg b.w. of leaf extract respectively.
Saline, leaf extract and the standard drug were admin-
istered orally using a mouth gauge. During the study
period, body weight, food and water intake of rats were
monitored regularly.
After initial determination of 16 h fasting blood glucose
levels (blood drawn through the tail vein puncture) animals
were given single intraperitoneal injection of streptozotocin at a
dose of 45 mg/kg b.w. freshly dissolved in cold 0.9 % saline
[10]. Fasting blood glucose levels were recorded after 5 days.
Animals that developed stable hyperglycemia with fasting
blood glucose levels more than 200 mg/dl were selected for
the study.
Rats were fasted overnight; blood was drawn from the
tail by tail vein puncture during the experimental period and
from cardiac puncture at the end of the experimental period
(after 28 days) under anaesthesia. Serum was separated by
centrifuging the collected blood samples at 10,000 rpm for
10 min at 4 ° C and used for the estimation of creatinine and
urea.
Urine from normal control rats, diabetic and treated dia-
betic rats were collected under a layer of toluene by keeping
the rats in metabolic cages for 24 h. Collected urine samples
were filtered through filter paper, centrifuged and stored at
4 ° C until further analysis.
Preparation of liver tissue homogenate
After 28 days, rats were dissected under anaesthesia. Liver
was rinsed in ice cold distilled water followed by chilled
0.9 % saline. About 1 g of liver tissue was homogenized in
10 ml of 10 mM phosphate buffered saline (pH 7.4) using
REMI homogenizer fitted with a teflon plunger. The
homogenate was centrifuged at 10,000 rpm at 4° C for
15 min and the supernatant was used for the determi-
nation of antioxidant liver enzymes like superoxide dis-
mutase (SOD), catalase and glutathione peroxidase
(GSH-Px).
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Analytical Methods
Fasting blood glucose was measured by glucose oxidase-
peroxidase (GOD-POD) method in mg/dl using a digital
glucometer (Braun OmnitestR EZ, Germany) [11]. Creati-
nine estimation was carried out in both serum and urine
samples [12]. Blood urea was estimated by enzymatic UV-
kinetic method [13]. The activity of SOD was assayed in a
Daytona analyser using commercially available diagnostic
SOD kit [14]. The activity of catalase was assayed based on
the hydrogen peroxide decomposition method [15]. The
activity of glutathione peroxidase was assayed in an auto-
matic analyser using glutathione peroxidase kit [16].
Histopathological studies
At the end of the study, the rats were sacrificed, whole
pancreas from each animal was removed, washed in normal
saline and fixed in 10 % formalin, embedded in paraffin and
sections of 3–5 μ thickness were cut and routinely stained
with basic dye hematoxylin and acidic dye eosin to differ-
entiate the nucleus and cytoplasm. The sections were
studied for the islet cell characteristics using a binocular
compound microscope.
Statistical analysis
All the values were expressed as mean ± standard error of
mean (SEM). Statistical difference was evaluated by using
one way analysis of variance (ANOVA) followed by
Turkeys post hoc test. Data were considered statistically
significant at P value≤0.05.
Results
Effect of leaf extract on blood glucose level
The anti-hyperglycemic effect of the extract on the
fasting blood glucose levels of diabetic rats is shown
in Table 1. Administration of streptozotocin increased
the blood glucose level by 68.7 % in diabetic control
rats which was maintained over a period of 4 weeks.
Daily treatment of ethanol extract of T. foenum graecum
leaves at a concentration of 250 and 500 mg/kg b.w. for
a period of 28 days led to a dose dependent fall in the
blood glucose levels by 23.5 % (P00.000) and 31.2 %
(P00.000) respectively. The glucose lowering effect of
the extract seems to reach a maximum after 25 days of
treatment and remained almost constant during the next
4–5 days. The effect was more pronounced with animals
receiving 500 mg/kg b.w. of extract which can be compared to
that of glibenclamide. The fasting glucose levels in normal
control rats and normal control rats fed with the extracts were
found to be stable all throughout the experimental period.
Effect of leaf extract on body weight
Prior to streptozotocin administration, there was no signifi-
cant difference in the average body weight of all the seven
groups of experimental animals. By the end of the first week
after DM was experimentally induced, the weights of group
D, E, F, and G were significantly reduced as shown in
Table 2. This weight loss continued for 4 weeks in diabetic
control animals (36.3 %). However, the weight of animals in
groups F and G increased by 42 % (P00.000) and 44.9 %
(P00.000) on treatment with 250 and 500 mg/kg b.w. of T.
foenum graecum leaf extract. At the end of the experimental
period there was a significant difference in the weights of
groups F and G as compared to group D. Animals in groups
A, B and C showed an increase in their body weights during
the experimental period.
Effect on kidney parameters
The effect of T. foenum graecum leaf extract on serum and
urinary creatinine and serum urea is shown in Table 3. Diabetic
control rats exhibited higher serum creatinine, urinary creati-
nine and blood urea levels compared to those of normal rats.
The creatinine and urea levels were significantly decreased by
glibenclamide and the extract by 28 days of treatment. The
extract at a concentration of 500 mg/kg b.w. showed a greater
decrease in serum creatinine (73.62 %, P00.000), urinary
creatinine (62.7 %, P00.000) and serum urea (50.6 %, P0
0.000) levels which was even better than glibenclamide treated
rats. There were no changes in the creatinine and urea levels in
normal extract treated controls (group B and C) as compared to
the normal control animals.
Effect on liver antioxidant enzymes
As shown in Table 4, streptozotocin induced diabetic control
rats showed a decrease in SOD (3.23 U/mg protein), catalase
(6.37 U/min/mg protein) and GSH-Px (3.45 U/mg protein)
as compared to the normal rats. Administration of T. foenum
graecum leaf extract for 28 days produced a marked in-
crease in the enzyme activities in both F and G groups.
There was a greater increase in the activity of SOD
(14.7 %, P00.000) in diabetic rats treated with 500 mg/kg
b.w. of extract when compared to glibenclamide treated rats.
There was an increase in the enzyme activities in group B
and C animals also.
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Histopathological studies
As shown in Fig. 1, in the diabetic group, degeneration with
reduction in the number and reduced dimensions of the
islets were observed in the pancreas. In animals treated with
250 mg/kg b.w. of the extract, the restoration of the normal
cellular population and size of islets were noted especially in
the central β cell region. In animals treated with 500 mg/kg
b.w. of the extract, there was not only an increase in the
cellular population and size of the islets but also there was
an increase in the number of islets noted. The regeneration
noted in the β cell regions was comparable to that noted
with glibenclamide.
Discussion
Streptozotocin, N-[methylnitrocarbamoyl]-D-glucosamine,
is a potent methylating agent for DNA and acts as nitric
oxide donor in pancreatic cells. β cells are particularly
sensitive to damage by nitric oxide and free radicals because
of their low levels of free radical scavenging enzymes [17].
For the study of antihyperglycemic agents, streptozotocin
induced hyperglycemia in rodents is considered to be a good
preliminary screening model [18].
Streptozotocin induced diabetes produced a significant
increase in glucose levels. Treatment with ethanol extract
of T. foenum graecum leaves showed significant decrease in
glucose levels which was near to glibenclamide treated
control. Decrease in blood glucose levels were found to
be more effective with 500 mg/kg b.w. of extract which
showed its dose dependent effects. Glibenclamide
showed rapid normalization of blood glucose due to
its insulin releasing effects. Earlier studies by various
workers have shown the antihyperglycemic activity of T.
foenum graecum seeds in a dose dependent manner in
experimentally induced diabetic rats [19, 20]. The anti-
diabetic plant extracts may involve one or more com-
pounds which decrease blood glucose suggesting that
the natural constituents could act synergistically to induce a
hypoglycemic effect [21].
Induction of diabetes with streptozotocin is associated
with a characteristic loss of body weight, which is probably
due to muscle wasting [22]. In our study, there was a
Table 1 Effect of ethanol extract of Trigonella foenum graecum leaves on glucose level in normal and streptozotocin induced diabetic rats (N06)
Groups Fasting blood glucose levels (mg/dl)
Day 0 Day 7 Day 14 Day 21 Day 28
Group A Normal control (0.9 % NaCl) 77.0±1.82 78.25±0.95 77.75±2.21 79.50±2.64 79.25±1.70
Group B Normal rats with extract (250 mg/kg b.w) 78.75±2.62 78.0±3.16 78.50±2.88 79.25±2.21 79.50±1.29
Group C Normal rats with extract (500 mg/kg b.w) 78.50±3.10 79.25±2.50 78.75±2.50 79.75±2.98 78.25±2.75
Group D STZ induced diabetic control 246.25±9.53* 284.0±5.47* 309.50±8.73* 319.75±7.80* 319.50±8.66*
Group E STZ+ glibenclamide (0.5 mg/kg b.w) 248.50±13.52 222.2±7.27** 190.0±4.54** 178.25±6.80** 157.75±8.95**
Group F STZ+ extract (250 mg/kg b.w) 248.25±10.65 240.0±12.27** 226.50±8.58** 208.5±7.41** 189.75±6.39**
Group G STZ+ extract (500 mg/kg b.w) 243.25±12.03 229.0±11.40** 204.0±6.21** 184.50±5.44** 167.25±7.80**
Values are expressed as mean ± S.E.M.; *- significantly different from normal control (P≤0.05); **- significantly different from diabetic control (P≤0.05)
Table 2 Effect of treatment of Trigonella foenum graecum leaf extract on body weight of normal and streptozotocin induced diabetic rats (N06)
Groups Average body weight (g)
Day 1 Day 7 Day 14 Day 21 Day 28
Group A Normal control rats (0.9 % NaCl) 142.50±5.0 146.25±2.50 152.50±5.0 160.0±4.08 166.25±4.78
Group B Normal rats with extract (250 mg/kg b.w) 140.0±0.0 145.0±4.08 153.75±4.78 158.75±4.78 163.75±4.71
Group C Normal rats with extract (500 mg/kg b.w) 140.0±8.16 146.25±4.78 153.75±7.50 161.25±8.53 165.0±9.12
Group D STZ induced diabetic control 135.50±5.77 115.0±5.77* 105.0±5.77* 95.0±4.08* 86.25±4.78*
Group E STZ+ glibenclamide (0.5 mg/kg b.w) 132.5±05.0 120.0±8.16** 125.0±5.77** 123.75±4.78** 126.25±2.50**
Group F STZ+ extract (250 mg/kg b.w) 127.5±05.0 117.50±2.88** 116.25±4.78** 120.0±4.08** 122.5±2.88**
Group G STZ+ extract (500 mg/kg b.w) 133.75±4.78 121.25±2.50** 123.75±2.50** 124.50±4.20** 125.0±4.08**
Values are expressed as mean ± S.E.M.; *- significantly different from normal control (P≤0.05); **- significantly different from diabetic control (P≤0.05)
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significant weight loss in the diabetic rats, whereas treat-
ment with the ethanol extract of leaves of T. foenum grae-
cum at both the doses showed improvement in their body
weight, indicating that the extract had beneficial effect in
preventing loss of body weight of diabetic rats. The proba-
ble mechanism is due to its effect in controlling muscle
wasting [23]. The metabolic disorders were corrected after
the administration of plant extract for 28 days as shown by
reduction in polyphagia, polyuria and polydipsia in diabetic
rats treated with plant extract. This could be the result of
improved glycemic control produced by ethanol extract of T.
foenum graecum.
Diabetic nephropathy is the leading cause of DM related
morbidity and mortality. The pathogenesis of diabetic ne-
phropathy is related to chronic hyperglycemia and hemody-
namic alterations in renal microcirculation and structural
changes in glomerulus as evident by the significant eleva-
tion in creatinine and urea levels [24]. Elevated creatinine
and urea levels were significantly decreased in diabetic rats
treated with T. foenum graecum extract which indicated its
beneficial effects on kidney. The result indicate that the
ethanol extract of T. foenum graecum leaves does not alter
the kidney function, as it is evident from the normal creatinine
and urea levels in normal control animals treated with the
extract (both 250 and 500 mg/kg b.w.) for a period of 28 days.
Diabetes is usually accompanied by increased production
of free radicals [25]. Free radicals are capable of damaging
cellular molecules, DNA, proteins and lipids leading to
altered cellular functions [26]. Abnormally high levels of
free radicals and simultaneous decline of antioxidant de-
fence mechanisms can lead to increased lipid peroxidation
and development of insulin resistance [27]. In the present
study, diabetic control rats showed significant decrease in
SOD, catalase and GSH-Px levels in rat liver homogenate
compared to normal rats, indicating dysfunction in antioxi-
dant defensive system. Treatment with ethanol extract of T.
foenum graecum leaves increased SOD, catalase and GSH-
Px levels in diabetic rat liver homogenates which were
comparable to that of glibenclamide treated rats. Vitamin
C and β carotene have been shown to be present in T.
foenum graecum leaves [28]. Effect of Vitamin C, E and β
carotene in elevating the antioxidant enzyme activities in
diabetic rats has been proved [29]. Phenolics, which are the
potential antioxidants are also present in T. foenum graecum
leaves [30]. So, the activity of the extract in the present
study is probably due to the presence of Vitamin C, β
Table 3 Effect of treatment of Trigonella foenum graecum leaf extract on serum creatinine, urinary creatinine and serum urea levels in normal and
streptozotocin induced diabetic rats (N06)
Groups Treatment Serum creatinine (mg/dl) Urinary creatinine (mg/day) Serum urea (mg/dl)
A Normal control rats (0.9 % NaCl) 0.47±0.04 18.72±1.83 23.74±0.73
B Normal rats with extract (250 mg/kg b.w) 0.41±0.08 18.72±0.62 23.62±0.79
C Normal rats with extract (500 mg/kg b.w) 0.36±0.05* 18.32±0.36 23.42±0.74
D STZ induced diabetic control 1.82±0.17* 51.52±3.76* 61.94±1.54*
E STZ+ glibenclamide (0.5 mg/kg b.w) 0.60±0.07** 23.61±2.38** 29.73±0.59**
F STZ+ extract (250 mg/kg b.w) 0.50±0.03** 22.22±2.30** 32.63±0.29**
G STZ+ extract (500 mg/kg b.w) 0.48±0.01** 19.17±0.84** 30.55±0.44**
Values are expressed as mean ± S.E.M.; *- significantly different from normal control (P≤0.05); **- significantly different from diabetic control (P≤0.05)
Table 4 Effect of ethanol extract of Trigonella foenum graecum leaves on liver antioxidant enzymes in normal and streptozotocin induced diabetic
rats (N06)
Groups Treatment Superoxide dismutase
(units/mg protein)
Catalase
(units/min/mg protein)
Glutathione peroxidase
(units/mg protein)
A Normal control rats (0.9 % NaCl) 10.50±0.54 10.70±1.13 5.73±0.28
B Normal rats with extract (250 mg/kg b.w) 12.39±0.75* 11.12±0.40 6.08±0.18
C Normal rats with extract (500 mg/kg b.w) 14.15±0.26* 11.35±0.42 6.30±0.24*
D STZ induced diabetic control 3.23±0.30* 6.37±0.48* 3.45±0.36*
E STZ+ glibenclamide (0.5 mg/kg b.w) 10.02±0.33** 8.82±0.63** 5.26±0.27**
F STZ+ extract (250 mg/kg b.w) 10.08±0.43** 7.52±0.61** 4.93±0.16**
G STZ+ extract (500 mg/kg b.w) 11.50±1.26** 8.32±0.40** 5.48±0.17**
Values are expressed as mean ± S.E.M.; *- significantly different from normal control (P≤0.05); **- significantly different from diabetic control (P≤0.05)
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carotene or phenolic antioxidant constituents. An increase in
the liver antioxidant enzymes in non diabetic control rats
treated with the leaf extract of T. foenum graecum showed
their non-toxic nature on the liver. The improvement in the
enzyme activities in non-diabetic control rats with extracts
when compared with the non diabetic control rats without
extracts is indicative of better liver function. The result of
our study is in agreement with the earlier study on fenugreek
seeds [31].
Degeneration and necrosis of the islets of pancreas in
diabetic rats was observed similar to the observation of
Selvan [32]. Our study has shown the regeneration of islet
cells especially in the β cell region. Similar effects in
streptozotocin treated diabetic animals were reported [33,
34]. The effect of the plant extract in regeneration in the β
cell region might be due to the presence of β carotene [35].
Photomicrographical data in our studies reinforce the
healing of pancreas, by T. foenum graecum leaf extract as
a plausible mechanism of their antidiabetic activity.
In conclusion, our data suggest that the ethanol leaf
extract of T. foenum graecum possess significant antidia-
betic activity as it lowers blood glucose levels in diabetic
rats. It also increases body weight of diabetic rats. The
ethanol extract was seen to be effective in preventing the
rise of creatinine and urea levels and thus improve the
kidney functions which were impaired in the streptozotocin
induced diabetic rats. In addition to this, the extract was not
found to exert any toxic side effects in the extract-fed
normal rats as seen by the normal creatinine and urea levels.
The extract has shown to induce regeneration and restora-
tion of the normal morphology of the islets of pancreas.
Along with the antihyperglycemic activity, the extract was
found to possess potential antioxidant activity and enhanced
antioxidant status of the diabetic rats. The present study
Fig. 1 Photomicrographs of rat
pancreas stained by H and E
stain of normal a and diabetic b
rats and effects of glibenclamide
c, 250 mg/kg b.w. ethanol extract
d and 500 mg/kg b.w. ethanol
extract e of Trigonella foenum
graecum. Microscope
magnification (40x)
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suggests that the leaves of T. foenum graecum can be uti-
lized for the management of diabetes, but further studies on
the nature of active principles involved and their mechanism
of action need to be studied.
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